EUCTR2004-001503-36-ES进行中（未招募）1 期
utropin alfa (Luveris) in mid follicular phase for controlled ovarian stimulation (COS) in ovarian ageing: a randomised, comparative with parallel control group, phase II clinical trial. - Lutropin alfa in mid follicular phase
SERONO ESPAÑA, S.A.0 个研究点目标入组 0 人开始时间: 2004年10月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1)Pre-menopausal woman, aged between 35 and 40 years of age inclusive, wishing to conceive.
- •2)Baseline (early follicular, day 2-5) FSH serum level £ 10 IU/l assessed within the past 6 months as well as LH and E2 levels within local normal range.
- •3)Having regular spontaneous menstrual cycle lasting 25-35 days.
- •4)Infertility justifying IVF/ET or ICSI treatment.
- •5)Controlled ovarian stimulation with r-hFSH under long GnRH agonist protocol.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1)Known to be HIV, HBV/HCV positive.
- •2)Any clinically significant systemic disease; tumours of the hypothalamus and pituitary gland; ovarian, uterine or mammary cancer; hormonal abnormality and/or medical, biochemical, hematological condition which in the judgement of the investigator may interfere with gonadotropin treatment.
- •3)More than 2 previous ART cycles
- •4)Cancellation of two previous cycles.
- •5)Cryopreserved embryos from previous ART cycles
研究者
相似试验
进行中（未招募）
1 期
utropin alfa in mid follicular phase in women at risk of poor response suppresed with cetrorelix: an exploratory trial.Lutropina alfa en mitad de la fase folicular en mujeres con riesgo de pobre respuesta en supresión con cetrorelix: estudio exploratorio - Lutropin alfa in risk of poor response.EUCTR2005-002229-30-ESSerono España, S.A.
进行中（未招募）
1 期
utropina alfa (Luveris®) en mitad de la fase folicular de la estimulación ovárica controlada (COS) en la edad reproductiva avanzada. Estudio clínico en fase II. - Lutropina alfa en edad reproductiva avanzadaEstimulación ovárica controlada para reproducción asistidaMedDRA version: 14.1Level: PTClassification code 10003539Term: Assisted fertilisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2006-005268-19-ESMerck, S.L.
进行中（未招募）
1 期
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesCTIS2024-513998-48-00niversitair Ziekenhuis Brussel50
进行中（未招募）
1 期
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesEUCTR2022-003049-37-BEZ Brussel50
终止
2 期
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive AgeOvulation InductionInfertilityNCT01079949Merck KGaA, Darmstadt, Germany93